Clin Infect Dis. 2004 Feb 1;38(3):438-41. Epub 2004 Jan 13.

Syringe distribution to injection drug users for prevention of HIV infection: opinions and practices of health care providers in New York City.

Coffin PO, Fuller C, Blaney S, Vadnai L, Miller S, Vlahov D.

Source

Center for Urban Epidemiologic Studies, New York Academy of Medicine, USA. pcoffin@nyam.org

Abstract

The Expanded Syringe Access Demonstration Program (ESAP), which was intended to increase access to syringes for injection drug users (IDUs), went into effect in New York State on 1 January 2001. ESAP allowed prescription-authorized health care providers to register to distribute syringes without a prescription. In spring 2002, we conducted a random postal survey of 1100 providers in New York City to evaluate involvement in ESAP and willingness to furnish IDUs with syringes. Among 363 nurse practitioners, physicians, and physician assistants responding, 16.9% knew about ESAP, and 2.0% believed they were registered; 50.5% would consider distributing syringes to patients who were IDUs. Most of those unwilling to distribute syringes were concerned about legal and moral issues. More respondents agreed that providers should prescribe syringes than distribute syringes (41.1% vs. 22.7%; P<.0001). These results suggest that many providers are willing to furnish IDUs with syringes but are unaware of the current law.

PMID:: 14727219; [PubMed - indexed for MEDLINE]

Free full text

Publication Types, MeSH Terms

Publication Types

Research Support, U.S. Gov't, P.H.S.

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

HIV/AIDS - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users. [J Am Pharm Assoc (Wash). 2002]
More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users.
Coffin PO, Ahern J, Dorris S, Stevenson L, Fuller C, Vlahov D. J Am Pharm Assoc (Wash). 2002 Nov-Dec; 42(6 Suppl 2):S62-7.
New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access. [J Urban Health. 2000]
New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access.
Coffin PO, Linas BP, Factor SH, Vlahov D. J Urban Health. 2000 Dec; 77(4):781-93.
Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. [J Am Pharm Assoc (Wash). 2002]
Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York.
Fuller CM, Ahern J, Vadnai L, Coffin PO, Galea S, Factor SH, Vlahov D. J Am Pharm Assoc (Wash). 2002 Nov-Dec; 42(6 Suppl 2):S77-82.
Review Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach. [Int J Drug Policy. 2007]
Review Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA. Int J Drug Policy. 2007 Oct; 18(5):417-25. Epub 2007 Feb 20.
Review HIV prevention among injection drug users: the need for integrated models. [J Urban Health. 2003]
Review HIV prevention among injection drug users: the need for integrated models.
Metzger DS, Navaline H. J Urban Health. 2003 Dec; 80(4 Suppl 3):iii59-66.

See reviews... See all...

Cited by 1 PubMed Central article

Review Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. [Clin Infect Dis. 2005]
Review Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.
Edlin BR, Kresina TF, Raymond DB, Carden MR, Gourevitch MN, Rich JD, Cheever LW, Cargill VA. Clin Infect Dis. 2005 Apr 15; 40 Suppl 5:S276-85.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Syringe distribution to injection drug users for prevention of HIV infection: op...
Syringe distribution to injection drug users for prevention of HIV infection: opinions and practices of health care providers in New York City.
Clin Infect Dis. 2004 Feb 1 ;38(3):438-41. Epub 2004 Jan 13 .

PubMed
Screening for early lung cancer with low-dose spiral computed tomography: result...
Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers.
Eur Radiol. 2004 Apr ;14(4):691-702. Epub 2004 Jan 16 .

PubMed
Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory...
Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis.
EMBO J. 2004 Jan 28 ;23(2):386-95. Epub 2004 Jan 15 .

PubMed
Antimicrobial treatment guidelines for acute bacterial rhinosinusitis.
Antimicrobial treatment guidelines for acute bacterial rhinosinusitis.
Otolaryngol Head Neck Surg. 2004 Jan ;130(1 Suppl):1-45.

PubMed
An epidemiologic assessment of genomic profiling for measuring susceptibility to...
An epidemiologic assessment of genomic profiling for measuring susceptibility to common diseases and targeting interventions.
Genet Med. 2004 Jan-Feb ;6(1):38-47.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: